IFC-Backed Biovac Achieves Major Milestone, Begins Clinical Trials for Africa’s First Domestically Developed Cholera Vaccine
CAPE TOWN, South Africa, Dec 2 – Biovac, International Finance Corporation (IFC) client has commenced clinical trials for South Africa’s first domestically developed oral cholera vaccine, marking a historic and crucial milestone in bolstering Africa’s health security and self-sufficiency in vaccine production. The breakthrough promises sustainable vaccine sovereignty for the continent, providing rapid and reliable…
